Health

Business Wire Australia and New Zealand

PRØHBTD to Host ‘The Future of Cannabis’ Workshop Sessions at Advertising Week APAC

23-Jul-2018 8:31 AM
Activations and Thought Leadership Panels in Sydney, Australia Will Be Followed by Return of ‘Cannabis Crossover’ at Advertising Week New York in October LOS ANGELES--(BUSINESS WIRE)--In a continuation of its exclusive strategic

Business Wire Australia and New Zealand

AVITA Medical Announces Expansion of Management Team to Support Planned U.S. Launch of RECELL® Device

20-Jul-2018 10:47 AM
VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH) (OTCQX: AVMXY) today announced that it expanded its management team in the commercial, legal and medical affairs functions to support the planned

Business Wire Australia and New Zealand

Gynesonics Names George Quinoy Vice President, Global Sales

20-Jul-2018 9:36 AM
Veteran Medical Device Executive to Lead the Development of High Performance Global Sales and Commercial Team REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, a women’s healthcare company focused on the development of minimally invas

Business Wire Australia and New Zealand

Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint

20-Jul-2018 9:31 AM
Trajenta® demonstrates long-term cardiovascular safety in adults with type 2 diabetes INGELHEIM, Germany & INDIANAPOLIS, Ind.--(BUSINESS WIRE)--CARMELINA®1 (CArdiovascular safety and Renal Microvascular outcomE wi

Business Wire Australia and New Zealand

New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

19-Jul-2018 3:49 PM
Data to be discussed with global health authorities, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)   OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited [TSE:4502] (“

Business Wire Australia and New Zealand

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease

19-Jul-2018 8:43 AM
Results showed a significant improvement in these measures: lower median number of sickle cell crises, fewer hospitalizations, lower cumulative days in hospital, and lower incidence of acute chest syndrome TORRANCE, Calif.--(BUSI

Business Wire Australia and New Zealand

22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan

18-Jul-2018 9:02 AM
Reynolds American and Phillip Morris unable to comply with the FDA’s plan “for 20-years” WILLIAMSVILLE, New York--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in t

Business Wire Australia and New Zealand

EUSA Pharma: NICE Approves the Targeted Cancer Immunotherapy, QARZIBA®? (dinutuximab beta) to Treat Children with High-Risk Neuroblastoma

12-Jul-2018 10:19 AM
HEMEL HEMPSTEAD, England--(BUSINESS WIRE)--EUSA Pharma today welcomed a decision by the National Institute for Health and Care Excellence (NICE) to recommend the use of the targeted cancer immunotherapy, QARZIBA® (dinutuximab b

Business Wire Australia and New Zealand

ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers

12-Jul-2018 9:48 AM
SAN DIEGO & SOUTH SAN FRANCISCO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, today announced their agreement to form a new joint

Business Wire Australia and New Zealand

Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant

12-Jul-2018 9:08 AM
-Abstract to be Submitted for Presentation at the 2018 ASH Annual Meeting- CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the randomized, Phase 3 TOURMAL

Business Wire Australia and New Zealand

iSchemaView Brings RAPID™ Imaging Platform to Australia and New Zealand Through Exclusive Distributor, Diagnostic Imaging Australia

12-Jul-2018 9:02 AM
State-of-the-Art Imaging Solution Provides Automated Scoring and Assessment of Brain Ischemia — Expanding the Treatment Window for Certain Acute Ischemic Strokes to Twenty-Four Hours After Onset REDWOOD CITY, Calif.--(BUSINESS WIRE

Business Wire Australia and New Zealand

President Clinton to Deliver Closing Keynote Address on Eliminating Preventable Deaths in Hospitals at the 7th Annual World Patient Safety, Science & Technology Summit

11-Jul-2018 9:30 AM
President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, to speak at the 7th Annual World Patient Safety, Science & Technology Summit (Photo: Business Wire) IRVINE, Calif.--(BUSINES

Business Wire Australia and New Zealand

Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia

10-Jul-2018 9:37 AM
  Results showed a significant reduction in transfusion burden compared to placebo Safety profile generally consistent with previously reported data Regulatory submissions planned in the United States and Europe in the first hal

Business Wire Australia and New Zealand

Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield(TM)

06-Jul-2018 8:28 AM
LAC-Shield helps enhance immunity in a wide range of food and beverage applications TOKYO--(BUSINESS WIRE)--Morinaga Milk Industry Co., Ltd., (TOKYO:2264) today announced it has attained self-affirmed GRAS (generally recognize

Business Wire Australia and New Zealand

JPND and NIH Awards to Support New Transatlantic Collaborations

05-Jul-2018 9:07 AM
PARIS--(BUSINESS WIRE)--Two major research funding entities in the EU and US are joining forces for the first time to optimise and harmonise research into neurodegenerative diseases. The EU Joint Programme on Neurodegenerative Disease Resea

Business Wire Australia and New Zealand

Menarini and Orion Sign Regional Partnerships in Asia-Pacific

03-Jul-2018 7:06 PM
SINGAPORE--(BUSINESS WIRE)--A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacific”), a member of the Italian largest biopharmaceutical company Menarini Group, and Orion Corporation have signed a multi-year licensing agreement for Mena

Royal Flying Doctor Service

Health Funding Announcement - Wednesday 2.30pm, Launceston Airport (RFDS base)

03-Jul-2018 12:31 PM
Federal Rural Health Minister, Senator Bridget McKenzie and CEO of the Royal Flying Doctor Service of Australia, Dr Martin Laverty travel to Launceston to mark the Commonwealth’s commitment

Business Wire Australia and New Zealand

New Radiotherapy Prostate Cancer Treatment, SpaceOAR® Hydrogel, Now Available in Japan

03-Jul-2018 10:46 AM
Image 1: Representative diagram of how SpaceOAR® hydrogel creates space between the rectum and prostate. (Graphic: Business Wire) TOKYO--(BUSINESS WIRE)--Augmenix K.K. announces that SpaceOAR hydrogel, a soft, implanted absorbable

Business Wire Australia and New Zealand

Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia

03-Jul-2018 8:22 AM
New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first patient impl

Business Wire Australia and New Zealand

Takeda Global Headquarters Grand Opening

02-Jul-2018 7:06 PM
Takeda holds the grand opening of Takeda Global Headquarters in Nihonbashi, Tokyo, Japan. With Takeda Global Headquarters as a base, and a symbol of the company’s values, Takeda will further accelerate its transition into a global, values-ba